Abstract
Dysregulation of central serotonergic system may contribute to the pathophysiology of mood disorders. The recent animal model of rats deficient in tryptophan hydroxylase 2 (TPH2), the rate limiting enzyme of serotonin synthesis in the central nervous system, is an efficient tool to investigate whether a vulnerable genotype can be associated with brain pathology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
